PRNP and prion disease: This observed toxic phenomenon associated with increased dosage of PrP is not restricted to prion diseases, as other human progressive neuropathies including Alzheimer ́s and Parkinson ́s diseases are associated with aggregation of proteins induced by overexpression of wild type polypeptides [79–81].